Dear Doctor - Participate in the Survey on fecal microbiota transplantation "Fecal microbiota transplantation (FMT) is a procedure in which stool from a healthy donor is transplanted into the gastrointestinal tract of a person with a gut disorder. The goal of FMT is to restore the composition and function of the gut microbiome.Research on FMT is still in its early stages, but preliminary studies suggest that it may be an effective treatment for a variety of gut disorders, including Clostridium difficile infection (CDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). In addition, because the gut microbiome plays a role in immunity, there is interest in using FMT as a treatment for autoimmune diseases such as Crohn's disease and type 1 diabetes.Side effects of FMT are generally minor and include abdominal pain, bloating, diarrhea, and constipation. However, serious complications have been reported in rare cases, such as sepsis (a potentially life-threatening condition caused by infection).If you are considering FMT for yourself or a loved one, it is important to speak with a healthcare provider who is experienced in this procedure. Participate in Surveys "
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation